Ebola, ZMapp, And The §101 Guidance
As the ongoing Ebola virus outbreak in West Africa continues unabated, the world has looked on and cheered as experimental ZMapp anti-Ebola virus antibodies developed by MappBio — a biotech startup...To view the full article, register now.
Already a subscriber? Click here to view full article